e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Tuberculosis: public health and primary prevention
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012
M. J. Van der Werf, C. Ködmön, V. Hollo, A. Sandgren, P. Zucs (Stockholm, Sweden)
Source:
International Congress 2014 – Tuberculosis: public health and primary prevention
Session:
Tuberculosis: public health and primary prevention
Session type:
Oral Presentation
Number:
4480
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. J. Van der Werf, C. Ködmön, V. Hollo, A. Sandgren, P. Zucs (Stockholm, Sweden). Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012. Eur Respir J 2014; 44: Suppl. 58, 4480
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
Source: Eur Respir J 2012; 39: 619-625
Year: 2012
Drug resistance among new TB cases in some Russian regions
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis
Source: Eur Respir J 2002; 19: 765-775
Year: 2002
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes
Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018
Year: 2018
Tuberculosis endemia evolution in Romania’s regions 2008-2011
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Analysis of TB denotifications in North London (2003 – 2012)
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
Drug resistant tuberculosis in urban hotspot
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Factors associated with tuberculosis among prisoners in Bulgaria for the period 2004-2013
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
The risk of default in TB patients in the Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Tuberculosis (TB) in homeless population in Poland
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Tuberculosis in native and foreign born populations in Portugal
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Diagnosis of abdominal tuberculosis in East London, UK
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
The trend of tuberculosis in Bucharest between years 2001 – 2013
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Sustainability of Russian GLC approved projects and treatment success rate in Russian MDR-TB cohort 2010
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
European Union Standards for Tuberculosis Care
Source: Eur Respir J 2012; 39: 807-819
Year: 2012
Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease
Source: Eur Respir J 2016; 47:1345-1347
Year: 2016
Transmission pattern of MDR-TB in Singapore 2005-2015
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation
Source: Eur Respir J, 53 (1) 1802089; 10.1183/13993003.02089-2018
Year: 2019
Successful investigation of household TB contacts in Buriram Hospital during 2011-2012
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Breast tuberculosis in East London
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept